-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gimatecan in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gimatecan in Metastatic Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gimatecan in Metastatic Pancreatic Cancer Drug Details: Gimatecan (LBQ-707, STI-481)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gimatecan in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gimatecan in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gimatecan in Epithelial Ovarian Cancer Drug Details: Gimatecan (LBQ-707, STI-481)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lefamulin Acetate in Cystic Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lefamulin Acetate in Cystic Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lefamulin Acetate in Cystic Fibrosis Drug Details: Lefamulin Acetate or...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lefamulin Acetate in Complicated Skin And Skin Structure Infections (cSSSI)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lefamulin Acetate in Complicated Skin And Skin Structure Infections (cSSSI) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lefamulin Acetate in Complicated Skin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PAC-1 in Pancreatic Endocrine Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PAC-1 in Pancreatic Endocrine Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PAC-1 in Pancreatic Endocrine Tumor Drug Details: PAC-1 (also known...
-
Product Insights
NewClemedi AG Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Clemedi AG Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Clemedi AG (Clemedi) develops in vitro diagnostic (IVD) tests for antibiotic resistance and susceptibility in infectious diseases. The company is investigating tuberculosis IV test device to identify tuberculosis; IVD tests to detect sexually transmitted infections (STI) causing bacteria; and tests to diagnose hospital acquired infections (HAI) such as ventilator associated pneumonia, urinary tract and surgical infections. It also developed a...
-
Product Insights
Likelihood of Approval Analysis for Vulvovaginal Candidiasis
Overview How likely is it that the drugs in Vulvovaginal Candidiasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vulvovaginal Candidiasis Overview An excessive growth of yeast in the vagina that...
-
Product Insights
NewQuarterly Sweet Spreads pricing trends in China
Empower your strategies with our Quarterly Sweet Spreads pricing trends in China report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
NewBinx Health Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Binx Health Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for women’s health. The company develops its proprietary, desktop, PCR-based point-of-care molecular diagnostic platform for diagnosis and treatment for chlamydia (CT) and gonorrhea (NG), two of the most tested for sexually transmitted infections (STIs). The company’s...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ruxolitinib Phosphate in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Hypopharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ruxolitinib Phosphate in Hypopharyngeal Cancer Drug Details: Ruxolitinib (INCB18424, Jakafi,...